← Leaderboards
David Blask
Mary Imogene Bassett Hospital
$2,983,098
Attributed
$3,246,473
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $263.4K · FY2008–16$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,246,473 · 6
By mechanism
R01$2,191,777 · 2
R56$526,750 · 1
R21$496,946 · 1
R13$31,000 · 2
Top collaborators
- Steven M Hill2 shared
Others in their field
Top investigators on “Melatonin”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$31,281,465
- Charles A Czeisler · Brigham And Women'S Hospital$22,338,905
- Barbara L Parry · University Of California San Diego$15,293,787
- Mary A Carskadon · Emma Pendleton Bradley Hospital$14,437,207
- Mariana Gross Figueiro · Icahn School Of Medicine At Mount Sinai$14,166,139
- Frank A Scheer · Brigham And Women'S Hospital$10,823,520
Research focus
MelatoninCyclic AmpHormone TherapyMcf7 CellLinoleateCircadian RhythmsLaboratory RatBreast NeoplasmsNonhuman Therapy EvaluationHormone Regulation /Control MechanismFatty Acid MetabolismAthymic MouseWomanTissuesSignal TransductionGrowthMelatonin ReceptorsCancer RiskFutureMetabolicMalignant NeoplasmsFemaleBaseMediating
Grant awards (15)
Circadian Disruption by Light at Night Induces Intrinsic Tamoxifen Resistant Breast Cancer$263,375
R56 · FY2016 · CA
Circadian Disruption by Light at Night Induces Intrinsic Tamoxifen Resistant Breast Cancer$263,375
R56 · FY2015 · CA
Melatonin Supplementation in Complementary Breast Cancer Prevention$162,596
R21 · FY2011 · CA · contact PI
FASEB SRC on Melatonin Receptors: Actions and Therapeutics$15,000
R13 · FY2011 · NS · contact PI
Melatonin Supplementation in Complementary Breast Cancer Prevention$167,625
R21 · FY2009 · CA · contact PI
Melatonin Supplementation in Complementary Breast Cancer Prevention$166,725
R21 · FY2008 · CA · contact PI
FASEB Summer Research Conference 2008 - Melatonin Receptors: Actions and Therapeu$16,000
R13 · FY2008 · NS · contact PI
LIGHT DURING DARKNESS AND BREAST CANCER PROGRESSION$302,164
R01 · FY2004 · CA
Phytomelatonin and Cancer Prevention$279,938
R01 · FY2004 · CA
Phytomelatonin and Cancer Prevention$279,938
R01 · FY2003 · CA
LIGHT DURING DARKNESS AND BREAST CANCER PROGRESSION$239,956
R01 · FY2003 · CA
Phytomelatonin and Cancer Prevention$279,938
R01 · FY2002 · CA
LIGHT DURING DARKNESS AND BREAST CANCER PROGRESSION$239,956
R01 · FY2002 · CA
LIGHT DURING DARKNESS AND BREAST CANCER PROGRESSION$289,949
R01 · FY2001 · CA
Phytomelatonin and Cancer Prevention$279,938
R01 · FY2001 · CA